Solana Company HSDT
1.90 USD +0.07 (+3.84%)
Nov 11, 2026, 12:58 PM EST
1.83 Day range 1.91
1.19 52-week range 5.47
- YTD
- -34.43%
- 1 year
- -63.28%
- Market cap
- 123.37M
- Revenue (ttm)
- 594.00K
- EPS (ttm)
- 53.74
- Shares out
- 3.73M
- P/E ratio
- 0.04
- Forward P/E
- -0.40
- YTD return
- -34.43%
- 1-year return
- -63.28%
- Volume
- 322.22K
- Avg volume
- 515.14K
- Open
- 1.83
- Previous close
- 1.83
- Day's range
- 1.83 – 1.91
- 52-week range
- 1.19 – 5.47
- Beta
- 1.61
5D -0.21 (-10.29%)
Key statistics
- Enterprise value
- -4.37M
- PEG ratio
- 0.00
- Price / sales
- 6.03
- Price / book
- 0.29
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -28.90%
- Free cash flow
- -5.85M
- Total cash
- 6.39M
- Total debt
- 35.00K
- Return on equity
- -161.97%
- Short % of float
- 6.38%
- 50-day average
- 0.53168
- 200-day average
- 1.73
Analyst view
Price target (mean) —
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.94.
Financials — quick view
HSDT Revenue — quarterly 2.53M
HSDT Net income — quarterly -30.26M
HSDT EPS — quarterly -0.38
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.00 | -0.99 | — | — |
| Aug 12, 2024 | Jun 1, 2024 | 0.00 | -0.64 | — | — |
| May 13, 2024 | Mar 1, 2024 | 0.00 | -3.08 | — | — |
| Mar 28, 2024 | Dec 1, 2023 | -4.05 | -1.47 | +2.58 | +63.70% |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | -5.49 | — | — |
| Aug 10, 2023 | Jun 1, 2023 | -5.50 | -3.00 | +2.50 | +45.45% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 5, 2024 | Roth MKM | main | Buy | Buy |
About Solana Company
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- heliusmedical.com
News
Solana Company to Release Third Quarter 2026 Operating Results on November 11, 2026 
Solana Designated As Strategic Enterprise By Hong Kong SAR Government’s Office For Attracting Strategic Enterprises 
China vs. Crypto Isn’t Over Yet: Solana Company CEO Says Beijing Is Studying the Technology ‘Very Closely’ — 'They Know That's Not the Technology They Can Ignore' 
B. Riley Securities Maintains Buy on Solana, Raises Price Target to $4 
12 Health Care Stocks Moving In Friday's Intraday Session 
B. Riley Securities Maintains Buy on Solana, Raises Price Target to $3.5 - B. Riley Securities Maintains Buy on Solana, Lowers Price Target to $2.5
Full Transcript: Helius Medical Tech Q2 2026 Earnings Call 
Helius Medical Tech Q2 EPS $(0.38) Misses $(0.07) Estimate, Sales $2.526M Miss $3.600M Estimate 
12 Health Care Stocks Moving In Friday's After-Market Session
Your note
Sign in to keep a note on HSDT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ANDREEFF DANE C | Chief Executive Officer | Purchase | Dec 13, 2023 | 0 |
| BUCKMAN PAUL R | Director | Stock Award(Grant) | May 23, 2023 | 89,824 |
| PERKINS SHERRIE L. | Director | Stock Award(Grant) | May 23, 2023 | 90,040 |
| STRAW EDWARD M. | Director | Stock Award(Grant) | May 23, 2023 | 90,111 |
| WALTER BLANE | Director | Stock Award(Grant) | May 23, 2023 | 93,454 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Susquehanna International Group, LLP | 0.49% | 18,223 | 17.49K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.48% | 17,751 | 17.04K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.38% | 14,242 | 13.67K | Sep 29, 2024 |
| Vanguard Group Inc | 0.34% | 12,598 | 12.09K | Sep 29, 2024 |
| UBS Group AG | 0.34% | 12,762 | 12.25K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.13% | 4,792 | 4.60K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.45% | 16,638 | 15.97K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.34% | 12,598 | 12.09K | Sep 29, 2024 |
| Fidelity Series Total Market Index Fund | 0.12% | 4,530 | 4.35K | Oct 30, 2024 |